As of 2025-09-15, the Intrinsic Value of Forte Biosciences Inc (FBRX) is -17.08 USD. This FBRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.56 USD, the upside of Forte Biosciences Inc is -261.71%.
Based on its market price of 10.56 USD and our intrinsic valuation, Forte Biosciences Inc (FBRX) is overvalued by 261.71%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.08 - -17.08 | -17.08 | -261.71% |
| P/E | (36.34) - (51.71) | (45.25) | -528.5% |
| DDM - Stable | (20.05) - (60.31) | (40.18) | -480.5% |
| DDM - Multi | (14.16) - (34.65) | (20.28) | -292.0% |
| Market Cap (mil) | 131.26 |
| Beta | 2.85 |
| Outstanding shares (mil) | 12.43 |
| Enterprise Value (mil) | 25.12 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.51% |
| Cost of Debt | 5.00% |
| WACC | 8.09% |